Literature DB >> 24248674

"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.

Jacob J van den Berg1, Rochelle K Rosen, Dana E Bregman, Lara A Thompson, Kathleen M Jensen, Patrick F Kiser, David F Katz, Karen Buckheit, Robert W Buckheit, Kathleen M Morrow.   

Abstract

Women's initial understandings and anticipated acceptability of long-acting vaginal gels as potential anti-HIV microbicides was investigated by exploring the perceptibility variables associated with prototype formulations. Four focus groups with 29 women, aged 18-45, were conducted to consider gel prototypes with varied physicochemical and rheological properties. Participants responded favorably to the concept of long-acting vaginal gels as microbicides. Distinctions in understandings and stated needs regarding product dosing, characteristics, and effectiveness offer valuable insights into product design. Long-acting vaginal gels capable of protecting against HIV/STIs will be a viable option among potential users, with dosing frequency being an important factor in willingness to use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24248674      PMCID: PMC4018755          DOI: 10.1007/s10461-013-0652-4

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  25 in total

1.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

2.  A framework for examining the sustained acceptability of microbicides.

Authors:  Lawrence J Severy; Elizabeth Tolley; Cynthia Woodsong; Greg Guest
Journal:  AIDS Behav       Date:  2005-03

3.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

4.  A randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in Uganda.

Authors:  Anatoli Kamali; Helen Byomire; Catherine Muwonge; Julie Bakobaki; Clare Rutterford; Pius Okong; Albert Profy; Romano Byaruhanga; Stella Namukwaya; Sheena McCormack; Heiner Grosskurth; Andrew J Nunn; Charles J N Lacey
Journal:  Sex Transm Infect       Date:  2010-05-05       Impact factor: 3.519

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Acceptability of Carraguard vaginal gel use among Thai couples.

Authors:  Sara J Whitehead; Peter H Kilmarx; Kelly Blanchard; Chomnad Manopaiboon; Supaporn Chaikummao; Barbara Friedland; Jullapong Achalapong; Mayuree Wankrairoj; Philip Mock; Sombat Thanprasertsuk; Jordan W Tappero
Journal:  AIDS       Date:  2006-11-14       Impact factor: 4.177

8.  Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring.

Authors:  J Romano; B Variano; P Coplan; J Van Roey; K Douville; Z Rosenberg; M Temmerman; H Verstraelen; L Van Bortel; S Weyers; M Mitchnick
Journal:  AIDS Res Hum Retroviruses       Date:  2009-05       Impact factor: 2.205

9.  Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection.

Authors:  A Mohammed Fayaz; Zhujun Ao; Morkattu Girilal; Liyu Chen; Xianzhong Xiao; Pt Kalaichelvan; Xiaojian Yao
Journal:  Int J Nanomedicine       Date:  2012-09-24

10.  Drug-eluting fibers for HIV-1 inhibition and contraception.

Authors:  Cameron Ball; Emily Krogstad; Thanyanan Chaowanachan; Kim A Woodrow
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more
  19 in total

1.  Achieving the optimal vaginal state: using vaginal products and study gels in Uganda, Zimbabwe, and South Africa.

Authors:  Zoe Duby; Barbara Mensch; Miriam Hartmann; Elizabeth Montgomery; Imelda Mahaka; Linda-Gail Bekker; Ariane van der Straten
Journal:  Int J Sex Health       Date:  2017-03-27

2.  Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.

Authors:  Rochelle K Rosen; Jacob J van den Berg; Sara E Vargas; Natali Senocak; Julia G Shaw; Robert W Buckheit; Kelley Alison Smith; Kate Morrow Guthrie
Journal:  Contraception       Date:  2015-08-11       Impact factor: 3.375

3.  Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Authors:  Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 4.  Vaginal drug distribution modeling.

Authors:  David F Katz; Andrew Yuan; Yajing Gao
Journal:  Adv Drug Deliv Rev       Date:  2015-04-28       Impact factor: 15.470

5.  Acceptability and use of a dapivirine vaginal ring in a phase III trial.

Authors:  Elizabeth T Montgomery; Ariane van der Straten; Miria Chitukuta; Krishnaveni Reddy; Kubashni Woeber; Millicent Atujuna; Linda-Gail Bekker; Juliane Etima; Teopista Nakyanzi; Ashley J Mayo; Ariana Katz; Nicole Laborde; Cynthia I Grossman; Lydia Soto-Torres; Thesla Palanee-Phillips; Jared M Baeten
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

6.  User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness.

Authors:  Kate M Guthrie; Rochelle K Rosen; Sara E Vargas; Melissa Guillen; Arielle L Steger; Melissa L Getz; Kelley A Smith; Jaime J Ramirez; Erna M Kojic
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

7.  Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.

Authors:  Joseph G Rosen; Ju Nyeong Park; Kristin E Schneider; Rebecca Hamilton White; S Wilson Beckham; Jennifer L Glick; Katherine H A Footer; Susan G Sherman
Journal:  AIDS Behav       Date:  2022-04-01

8.  Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices.

Authors:  Sarah K Calabrese; Rachel W Galvao; John F Dovidio; Tiara C Willie; Cara B Safon; Clair Kaplan; Abigail Caldwell; Oni Blackstock; Nicole J Phillips; Trace S Kershaw
Journal:  AIDS Patient Care STDS       Date:  2020-03       Impact factor: 5.078

9.  Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.

Authors:  Ariane van der Straten; Lori Panther; Nicole Laborde; Craig J Hoesley; Helen Cheng; Marla J Husnik; Stephanie Horn; Annalene Nel; Lydia Soto-Torres; Beatrice A Chen
Journal:  AIDS Behav       Date:  2016-11

Review 10.  Recent Advances in Polymer-Based Vaginal Drug Delivery Systems.

Authors:  Tomasz Osmałek; Anna Froelich; Barbara Jadach; Adam Tatarek; Piotr Gadziński; Aleksandra Falana; Kinga Gralińska; Michał Ekert; Vinam Puri; Joanna Wrotyńska-Barczyńska; Bozena Michniak-Kohn
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.